Novacyt
Oncology and infectious disease diagnostic products.
HQ location
Vélizy-Villacoublay, France
Website
Launch date
Employees
Market cap
$39.1m
Enterprise value
$15m
Share price
£0.42 NCYT.L
Company register number
Recent deals
loading funding rounds…
| GBP | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | (32 %) | 2877 % | (65 %) | (78 %) | (45 %) | 70 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 6 % | (13 %) | 61 % | (1 %) | (48 %) | (110 %) | (127 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (35 %) | (50 %) | 48 % | (10 %) | (122 %) | (244 %) | (213 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | 3 % | 1 % | 5 % | 24 % | 28 % | 14 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Novacyt
Edit
ACQUISITION by Novacyt Oct 2020
ACQUISITION by Novacyt Jun 2014
ACQUISITION by Novacyt Jul 2023